Recombinant protective antigen vaccines (Pfenex)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRecombinant protective antigen vaccines (Pfenex)
Drug Alias NameRPA-563Px-563L SDIPx-563L-mrPAPx563L
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfenex Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfenex Inc
Active IndicationsN/A
Inactive IndicationsAnthrax

Other Information

ATC CodeN/A
Related LinksN/A